Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...
With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
This has some investors continuing to worry that the stock market in general might be overvalued. But there are always stocks that are cheaply priced. Below is a screen of stocks trading well ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN) stands against ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN ...
Virtually no clinical-stage biotech company is. However, Viking Therapeutics' progress in 2025 could again attract an army of investors to bid up its share price. So, the stock could deliver ...
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool.
Pharmala Biotech Holdings Inc. (market cap ... also highlighted strategic partnerships and operational efficiencies. The stock has shown remarkable momentum, surging 200% over the past six months to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results